Technical University of Munich: Synthetic Peptides as Basis for Multifunctional Drugs in Parkinson's Disease
April 25, 2025
April 25, 2025
MUNICH, Germany, April 25 -- The Technical University of Munich issued the following news:
* * *
Preventing harmful protein aggregation
Synthetic Peptides as basis for multifunctional drugs in Parkinson's disease
In Alzheimer's, Parkinson's, and type 2 diabetes, harmful protein aggregates and deposits, known as amyloid plaques, develop. There is also much evidence that these three diseases are interconnected and mutually reinforc . . .
* * *
Preventing harmful protein aggregation
Synthetic Peptides as basis for multifunctional drugs in Parkinson's disease
In Alzheimer's, Parkinson's, and type 2 diabetes, harmful protein aggregates and deposits, known as amyloid plaques, develop. There is also much evidence that these three diseases are interconnected and mutually reinforc . . .